Status:

COMPLETED

A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions:

Anemia

Blood Transfusion

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of epoetin alfa and to determine whether epoetin alfa will facilitate self-donation of blood before surgery in patients who have a...

Detailed Description

Patients undergoing major orthopedic surgery frequently require blood transfusions both during and after the operation. A large percentage of patients are not able to pre-deposit their own blood for t...

Eligibility Criteria

Inclusion

  • Patients scheduled for hip replacement surgery
  • having an anticipated requirement of 3 or more units of blood
  • having a hematocrit level \<=0.39
  • having a hemoglobin level \<= 12.5 grams/deciliter
  • having laboratory tests within normal ranges, including stool negative for occult blood

Exclusion

  • Patients with a history of any blood disease
  • having signs and symptoms of significant disease/dysfunction, or signs and symptoms of significant ongoing blood loss
  • having uncontrolled high blood pressure, or a folate, vitamin B12, or iron deficiency, or signs and symptoms suggestive of an autoimmune disease causing blood to break down and release iron-containing pigment
  • taking medication known to suppress the formation of red blood cells within 1 month before the start of the study
  • having a history of seizures, or the presence of active inflammatory disease (e.g., rheumatoid arthritis), however, patients with osteoarthritis may be included in this study

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 1991

Estimated Enrollment :

55 Patients enrolled

Trial Details

Trial ID

NCT00270114

End Date

March 1 1991

Last Update

May 18 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood) | DecenTrialz